StoneX Group’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-90,598
Closed -$930K – 782
2023
Q2
$930K Buy
+90,598
New +$925K 0.1% 183

StoneX Group's DALS Position: Q3 2023 in Review

StoneX Group sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 90,598 shares — an estimated $930K sold.

StoneX Group first reported a position in DALS in Q2 2023 and held it in 1 quarter. The position peaked at $930K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • StoneX Group reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • StoneX Group sold 90,598 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $930K.
  • StoneX Group first reported a position in DA32 Life Science Tech Acquisition Corp in Q2 2023 and held it in 1 quarter.
  • StoneX Group's DA32 Life Science Tech Acquisition Corp position peaked at $930K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on StoneX Group's 13F filing for Q3 2023, filed 15 Nov 2023.